Crystal structure of 2-((2,6-dichloro-4-(3,5-dimethylisoxazol-4-yl)phenyl)amino)-N-(2-(4-methylpiperazin-1-yl)ethyl)benzamide hydrate, C25H37Cl2N5O6-Reference-Cited by-同舟云学术

Crystal structure of 2-((2,6-dichloro-4-(3,5-dimethylisoxazol-4-yl)phenyl)amino)-N-(2-(4-methylpiperazin-1-yl)ethyl)benzamide hydrate, C₂₅H₃₇Cl₂N₅O₆

Published:2024-02-06 Issue:2 Volume:239 Page:277-279
ISSN:1433-7266
Container-title:Zeitschrift für Kristallographie - New Crystal Structures
language:en
Short-container-title:

Author:

Xu Xiaona¹,Tang Wenqiang²^ORCID,Zhu Zhoujing²,Liu Bin²^ORCID

Affiliation:

1. School of Pharmaceutical & Chemical Engineering, Xianyang Vocational Technical College , Xianyang , Shaanxi , China

2. Xianyang Key Laboratory of Molecular Imaging and Drug Synthesis, School of Pharmacy , Shaanxi Institute of International Trade & Commerce , Xianyang , Shaanxi , China

Abstract

Abstract C25H37Cl2N5O6, triclinic, P 1 ‾

$P\overline{1}$

(no. 2), a = 8.115(4) Å, b = 8.656(4) Å, c = 22.641(9) Å, α = 81.344(9)°, β = 80.173(9)°, γ = 65.833(8)°, V = 1423.9(10) Å3, Z = 2, R gt (F) = 0.0652, wR ref (F 2) = 0.2010, T = 173 K.

Publisher

Walter de Gruyter GmbH

Link

https://www.degruyter.com/document/doi/10.1515/ncrs-2023-0525/pdf

Reference15 articles.

1. Bruker. SAINT, APEX2 and SADABS; Bruker AXS Inc.: Madison, WI, USA, 2012.

2. Sheldrick, G. M. SHELXTL – integrated space-group and crystal-structure determination. Acta Crystallogr. 2015, A71, 3–8.

3. Sheldrick, G. M. Crystal structure refinement with SHELXL. Acta Crystallogr. 2015, C71, 3–8; https://doi.org/10.1107/s2053229614024218.

4. Dolomanov, O. V., Bourhis, L. J., Gildea, R. J., Howard, J. A. K., Puschmann, H. OLEX2: a complete structure solution, refinement and analysis program. J. Appl. Crystallogr. 2009, 42, 339–341; https://doi.org/10.1107/s0021889808042726.

5. Raja, G., Venkatesh, G., Al-Otaibi, J. S., Vennila, P., Mary, Y. S., Sixto-López, Y. Synthesis, characterization, molecular docking and molecular dynamics simulations of benzamide derivatives as potential anti-ovarian cancer agents. J. Mol. Struct. 2022, 1269, 133785; https://doi.org/10.1016/j.molstruc.2022.133785.